RecallHawk
Class III Recall

Atropine Sulfate Ophthalmic Solution, USP 1%, 5 mL bottles, Rx only, Manufactured for: Somerset Therapeutics, LLC. Somer

SOMERSET THERAPEUTICS LLC

Summary

The FDA issued a Class III for Atropine Sulfate Ophthalmic Solution, USP 1%, 5 mL bottles, Rx only, Manufacture by SOMERSET THERAPEUTICS LLC. Reason: Failed Impurities/Degradation Specifications.

Details

Source

Drug Recall

External ID

D-0169-2025

Action Date

2025-01-08

Status

Terminated

Category

drug

Product Description

Atropine Sulfate Ophthalmic Solution, USP 1%, 5 mL bottles, Rx only, Manufactured for: Somerset Therapeutics, LLC. Somerset, NJ 08873, NDC 70069-716-01

Lot/Code Info: Lot #: A240211, Exp. Date April 2026

Quantity Affected: 5,870 bottles

Reason for Recall

Failed Impurities/Degradation Specifications

Distribution

Nationwide within the United States

Type: Voluntary: Firm initiated

Recall Initiated: 2024-12-16

Company

Context & Analysis

This is a Class III recall. Class III recalls involve products unlikely to cause adverse health consequences, but that violate FDA regulations.

This was one of 31 drug recalls issued in the same week, part of 267 drug-related FDA actions this month.

SOMERSET THERAPEUTICS LLC has 6 FDA actions in our database, including 6 recalls.

Frequently Asked Questions

What is a Class III recall?

A Class III recall involves products that are unlikely to cause adverse health effects but violate FDA labeling or manufacturing regulations.

What should I do if I have this product?

Stop using the product. Check the product against the specific lot numbers or identifiers listed in the recall. Contact the manufacturer (SOMERSET THERAPEUTICS LLC) or your retailer for a refund or replacement. If you experienced adverse effects, report them to the FDA via MedWatch.

How often does SOMERSET THERAPEUTICS LLC have FDA actions?

SOMERSET THERAPEUTICS LLC has 6 FDA actions in our database, including 6 recalls and 0 device clearances.

Where can I find the official FDA record?

The official record is available on FDA.gov. Search for "D-0169-2025" on FDA.gov for the full record. You can also use the openFDA API to query this record programmatically.

Want to know the moment something like this happens?

Get alerts for drug

Related Actions